Enolase 1, all the more generally known as alpha-enolase, is a glycolytic catalyst communicated in many tissues, one of the isozymes of enolase. Each isoenzyme is a homodimer made out of 2 alpha, 2 gamma, or 2 beta subunits, and capacities as a glycolytic chemical. Little atom inhibitors of enolase have been orchestrated as concoction tests of the reactant component of the catalyst. Endeavors have been made to utilize this inhibitor as an enemy of trypanosome medication, and all the more as of late, as an enemy of malignant growth specialist. Enolase has a place with the group of lyases, explicitly the hydro-lyases, which sever carbon-oxygen bonds. The efficient name of this protein is 2-phospho-D-glycerate hydro-lyase (phosphoenolpyruvate-shaping). The response is reversible, contingent upon ecological groupings of substrates. Enolase is the catalyst liable for the reversible transformation of D-2-phosphoglycerate (2PGA) and phosphoenolpyruvate (PEP) in glycolysis and gluconeogenesis, two metabolic pathways that are frequently essential for cell work. On the off chance that the pH is excessively high or excessively low than the ideal pH, at that point the compound, for example, enolase will get denatured and it won't have the option to catalyze the response. An adjustment in pH causes the catalyst the state of a compound to get changed or it changes the particular charge properties of the substrate of that protein.